EUVIMEDEUVIMED entdecken
FallberichtVideo/Audio

Recurrent hypo‐attenuated leaflet thickening after TAVR: Clinical implications

Andrew Takla iD, Kirolus Sourial, Gaurav Sharma

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31017 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Andrew Takla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement, Aortic Valve, Aortic Valve Stenosis. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subclinical bioprosthetic valve thrombosis (BPVT) is a relatively common finding in asymptomatic patients during follow‐up imaging. However, its clinical significance is unclear. Data from registries associate BPVT with elevated valve gradients, thromboembolic complications, recurrence, and valve degeneration. Given the dynamic nature of the disease process, management is challenging. The duration of anticoagulation is unpredictable, and the need for frequent monitoring of BPVT, even in subclinical scenarios, is unclear. Our report is shedding the light on the clinical implications BPVT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisTranscatheter Aortic Valve ReplacementAortic ValveAortic Valve StenosisBioprosthesisRecurrenceThrombosisHumansTreatment OutcomeAged, 80 and overMaleProsthesis DesignFemaleAnticoagulantsAgedTime Factors

Stichwörter der Autor:innen

anticoagulants/antithrombins (ANCO)aortic valve disease (AVDP)clinical trials (CLIN)imaging computed tomography (IMCT)percutaneous interventionstructural heart disease intervention (SHDI)

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Department of Cardiovascular Medicine, Rochester General Hospital, Rochester, New York, USA.

ORCID-Profile: Andrew Takla

Zitieren

APA

Takla, A., Sourial, K., & Sharma, G. (2024). Recurrent hypo‐attenuated leaflet thickening after TAVR: Clinical implications. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31017

Vancouver

Takla A, Sourial K, Sharma G. Recurrent hypo‐attenuated leaflet thickening after TAVR: Clinical implications. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31017

BibTeX
@article{Takla2024,
  author = {Takla, Andrew and Sourial, Kirolus and Sharma, Gaurav},
  title = {Recurrent hypo‐attenuated leaflet thickening after TAVR: Clinical implications},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31017}
}
Kostenlos starten →